Both in Pharmaceuticals
Phibro Animal Health vs ArriVent BioPharma
Over the past year PAHC returned −9.5% and AVBP returned +62.7%; their daily moves had a correlation of 0.06.
PAHC −9.5% AVBP +62.7%Growth of $1, one year, split-adjusted
| Metric | PAHC | AVBP |
|---|---|---|
| Price | $35.45 | $29.54 |
| Market cap | $1.44B | $1.46B |
| Today | −0.70% | +0.82% |
| 1 month | −5.9% | −2.1% |
| 6 months | −33.6% | +40.6% |
| Year to date | −5.1% | +46.8% |
| 1 year | −8.7% | +63.8% |
| Revenue growth (YoY) | +4.8% | — |
| Gross margin | 33.9% | — |
| Net margin | 5.5% | — |
| P/E (TTM) | 14.4× | — |
| Price / sales | 0.9× | — |
| Net cash | -$650.8M | $373.1M |
| Dividend yield | 1.35% | — |
| Volatility (60d) | 31.2% | 54.5% |
| Short % of float | 5.5% | 28.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).